Back to top
more

The Cooper Companies (COO)

(Delayed Data from NSDQ)

$106.59 USD

106.59
1,235,653

+0.09 (0.08%)

Updated Sep 6, 2024 04:00 PM ET

After-Market: $106.55 -0.04 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (170 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

The Cooper Companies Inc (COO), based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI). CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness. CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.

Here's Why You Should Invest in Cooper Companies Stock Now

by Zacks Equity Research

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions.

XRAY vs. COO: Which Stock Is the Better Value Option?

by Zacks Equity Research

XRAY vs. COO: Which Stock Is the Better Value Option?

MCK vs. COO: Which Stock Is the Better Value Option?

by Zacks Equity Research

MCK vs. COO: Which Stock Is the Better Value Option?

Insulet (PODD) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Insulet (PODD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Sreyoshi Mukherjee headshot

Women Health a Top Priority Now: 3 Stocks to Watch

by Sreyoshi Mukherjee

Women's healthcare gains global importance, investors might want to keep an eye on these stocks.

Why Is Cooper Cos. (COO) Up 17.6% Since Last Earnings Report?

by Zacks Equity Research

Cooper Cos. (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Walgreens Boots (WBA) Q3 Earnings Top Estimates, Margins Dip

by Zacks Equity Research

Walgreens Boots' (WBA) Retail Pharmacy USA division gains traction from comparable prescription volume growth and a sturdy retail prescription market.

Boston Scientific Strong on Growth Goals and Future Launches

by Zacks Equity Research

This long-range strategy will aid Boston Scientific (BSX) to deliver a solid financial footing across its MedSurg, Rhythm and Neuro plus Cardiovascular segments.

Here's Why You Should Add Bruker (BRKR) to Your Portfolio

by Zacks Equity Research

Investor confidence in Bruker stock (BRKR) is high on substantial potential of MALDI Biotyper.

Bruker (BRKR) Hits a 52-Week High on Solid Growth Drivers

by Zacks Equity Research

Bruker (BRKR) gains from several crucial product launches and acquisitions.

Cooper Cos. (COO) Is Up 0.36% in One Week: What You Should Know

by Zacks Equity Research

Does Cooper Cos. (COO) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here's Why You Should Invest in Cooper Companies Stock Now

by Zacks Equity Research

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions.

Zacks.com featured highlights include: Cooper, GW, Tencent and Bloom

by Zacks Equity Research

Zacks.com featured highlights include: Cooper, GW, Tencent and Bloom

Tirthankar Chakraborty headshot

4 Stocks to Buy for Solid Earnings Acceleration

by Tirthankar Chakraborty

Studies show that a majority of successful stocks see acceleration in earnings before an uptick in the stock price.

Cooper Companies (COO) Q2 Earnings & Revenues Top Estimates

by Zacks Equity Research

Higher revenues, solid segmental performance and expansion in margins benefit Cooper Companies' (COO) Q2 earnings.

Cooper Cos. (COO) Q2 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Cooper Cos. (COO) delivered earnings and revenue surprises of 6.52% and 0.16%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?

Tirthankar Chakraborty headshot

5 Best-Performing Summer Stocks to Add to Your Watch List

by Tirthankar Chakraborty

We highlight five stocks that tend to do well during summer, the period between the Memorial Day and the Labor Day.

Can Segmental Growth Aid Cooper Companies' (COO) Q2 Earnings?

by Zacks Equity Research

Cooper (COO) expects to gain from CVI and CSI units in the fiscal second quarter.

Analysts Estimate Cooper Cos. (COO) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Cooper Cos. (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain Cooper Companies (COO) Stock

by Zacks Equity Research

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex volatility remains a concern.

Cerner and naviHealth Extend Partnership, Boost EHR Service

by Zacks Equity Research

Cerner (CERN) and naviHealth coordinate to provide EHR offering that is expected to benefit health care providers in the form of affordable and accessible health care centered on the patient.

Here's Why You Should Bet on Cooper Companies (COO) Stock Now

by Zacks Equity Research

Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across its segments and prudent acquisitions.

BD Introduces New Product to Reduce the Risk of Sepsis

by Zacks Equity Research

BD introduces new FDA cleared product to lower the risk of sepsis and combat platelet contamination.

Cooper Cos. (COO) Up 5.1% Since Last Earnings Report: Can It Continue?

by Zacks Equity Research

Cooper Cos. (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Cooper Companies' (COO) CooperVision Gains Momentum Globally

by Zacks Equity Research

Cooper Companies (COO) maintains its leading position in the markets of specialty lenses, supported by highly exclusive products like Biofinity and Clariti.